A 2015 roadmap for the management of hepatitis C virus infections in Asia
Seng Gee Lim, Yock Young Dan
Korean J Intern Med. 2015;30(4):423-433. Published online 2015 Jun 29 DOI: https://doi.org/10.3904/kjim.2015.30.4.423
Citations to this article as recorded by 
Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019
Nicolette Veracruz, Robert G. Gish, Ramsey Cheung, Amit S. Chitnis, Robert J. Wong
Journal of Viral Hepatitis.2022; 29(5): 352. CrossRef
Characteristics of patients with hepatitis C virus infection and antiviral treatment initiation in Taiwan: The MOSAIC study
Ming‐Lung Yu, Wei‐Lun Tsai, Chi‐Jen Chu, Jia‐Horng Kao
The Kaohsiung Journal of Medical Sciences.2021; 37(3): 245. CrossRef
Prevalence and genotype distribution of hepatitis C virus in Mongolia: Systematic review and meta-analysis
Karima Chaabna, Delgermaa Dashzeveg, Tserendulam Shagdarsuren, Rami H. Al-Rifai
International Journal of Infectious Diseases.2021; 105: 377. CrossRef
Affordability of Antiviral Therapy in Asia‐Pacific Countries and Its Impact on Public Health Outcomes
Prowpanga Udompap, Tawesak Tanwandee, Rino Gani
Clinical Liver Disease.2020; 16(6): 249. CrossRef
Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations
BYM Soh, R Kumar, VSM Ekstrom, CYH Lin, S Thangaraju, HH Tan, KP Chan, LHL Choong, D Teo, WC Chow
Singapore Medical Journal.2019; 60(1): 34. CrossRef
Systematic review with meta‐analysis: extrahepatic manifestations in chronic hepatitis C virus‐infected patients in East Asia
Zobair M. Younossi, Linda Henry, Janus P. Ong, Atsushi Tanaka, Yuichiro Eguchi, Masashi Mizokami, Young‐Suk Lim, Yock Young Dan, Ming‐Lung Yu, Maria Stepanova
Alimentary Pharmacology & Therapeutics.2019; 49(6): 644. CrossRef
A novel point-of-care oral anti-HCV assay: Is it reliable for screening hepatitis C virus infection in the era of direct-acting antivirals?
Rui-Feng Yang, Yan Liu, Cai-Yan Zhao, Ya-Xing Ding, Yu Chen, Ya-Dong Wang, Zhong-Ping Duan, Ming-Lung Yu
PLOS ONE.2019; 14(2): e0211795. CrossRef
Elbasvir/grazoprevir in Asia‐Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection
Jacob George, Eduard Burnevich, I‐Shyan Sheen, Jeong Heo, Nguyen Van Kinh, Tawesak Tanwandee, Pin‐Nan Cheng, Do Young Kim, Won Young Tak, Svetlana Kizhlo, Konstantin Zhdanov, Vasily Isakov, Liwen Liang, Pauline Lindore, Joy Ginanni, Bach‐Yen Nguyen, Janic
Hepatology Communications.2018; 2(5): 595. CrossRef
Pegylated Interferon-α Plus Ribavirin Therapy Improves Left Ventricular Diastolic Dysfunction in Patients With Chronic Hepatitis C Attaining Sustained Virological Response
Abdul-Quddus Mohammed, Ranshaka Auckle, Hai-Ling Li, Si-Ling Xu, Lu Liu, Dong-Dong Zhao, Wen-Liang Che
The American Journal of the Medical Sciences.2018; 355(6): 566. CrossRef
Real-world effectiveness of sofosbuvir plus ribavirin for chronic hepatitis C genotype 2 in Asia: a systematic review and meta-analysis
Bin Wei, Fanpu Ji, Yee Hui Yeo, Eiichi Ogawa, Biyao Zou, Christopher D Stave, Shuangsuo Dang, Zongfang Li, Norihiro Furusyo, Ramsey C Cheung, Mindie H Nguyen
BMJ Open Gastroenterology.2018; 5(1): e000207. CrossRef
Pathway to Hepatitis Elimination and Control
Seng Gee Lim, Guan Huei Lee
Annals of the Academy of Medicine, Singapore.2018; 47(11): 435. CrossRef
Urgency to treat patients with chronic hepatitis C in Asia
Jia‐Horng Kao, Sang Hoon Ahn, Rong‐Nan Chien, Mong Cho, Wan‐Long Chuang, Sook‐Hyang Jeong, Chen‐Hua Liu, Seung‐Woon Paik
Journal of Gastroenterology and Hepatology.2017; 32(5): 966. CrossRef
The ERAP gene is associated with HCV chronic infection in a Chinese Han population
Shuyuan Liu, Danfeng Cao, Yunsong Shen, Yalin Li, Ying Li, Li Shi, Jiankun Yu, Chuanyin Li, Xinwen Zhang, Mingbo Sun, Yufeng Yao
Human Immunology.2017; 78(11-12): 731. CrossRef
Daclatasvir/asunaprevir/beclabuvir, all‐oral, fixed‐dose combination for patients with chronic hepatitis C virus genotype 1
Jia‐Horng Kao, Ming‐Lung Yu, Cheng‐Yuan Peng, Jeong Heo, Chi‐Jen Chu, Ting‐Tsung Chang, Youn‐Jae Lee, Tsung‐Hui Hu, Ki Tae Yoon, Seung Woon Paik, Young Suk Lim, Sang Hoon Ahn, Vasily Isakov, Fiona McPhee, Wenhua Hu, Eugene Scott Swenson, Philip D Yin, Mic
Journal of Gastroenterology and Hepatology.2017; 32(12): 1998. CrossRef
Dual sofosbuvir and ribavirin therapy for chronic hepatitis C infection
L Tang, H Ward, S Kattakuzhy, E Wilson, S Kottilil
Expert Review of Gastroenterology & Hepatology.2016; 10(1): 21. CrossRef
CKD and Infectious Diseases in Asia Pacific: Challenges and Opportunities
Vivekanand Jha, Narayan Prasad
American Journal of Kidney Diseases.2016; 68(1): 148. CrossRef
Cost‐effectiveness of strategy‐based approach to treatment of genotype 1 chronic hepatitis C
Ying Jiao Zhao, Ai Leng Khoo, Liang Lin, Monica Teng, Calvin J Koh, Seng Gee Lim, Boon Peng Lim, Yock Young Dan
Journal of Gastroenterology and Hepatology.2016; 31(9): 1628. CrossRef
Time for Action on Viral Hepatitis
Seng Gee Lim
Annals of the Academy of Medicine, Singapore.2016; 45(1): 27. CrossRef